Advisor Shares Investments LLC Atai Life Sciences N.V. Transaction History

Advisor Shares Investments LLC

$505 Million
Q3 2024

A detailed history of Advisor Shares Investments LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Advisor Shares Investments LLC holds 167,831 shares of ATAI stock, worth $199,718. This represents 0.04% of its overall portfolio holdings.

Number of Shares

167,831

Previous 200,831 16.43%

Holding current value

$199,718

Previous $267,000 27.34%

% of portfolio

0.04%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.16 - $1.64 $38,280 - $54,120	-33,000 Reduced 16.43%	167,831 $194,000
Q2 2024 Aug 07, 2024	BUY	$1.27 - $2.6 $23,676 - $48,471	18,643 Added 10.23%	200,831 $267,000
Q1 2024 May 14, 2024	SELL	$1.5 - $2.19 $20,521 - $29,961	-13,681 Reduced 6.98%	182,188 $358,000
Q4 2023 Feb 13, 2024	BUY	$1.04 - $1.55 $18,039 - $26,886	17,346 Added 9.72%	195,869 $276,000
Q3 2023 Nov 06, 2023	BUY	$1.27 - $2.28 $23,655 - $42,467	18,626 Added 11.65%	178,523 $230,000
Q2 2023 Aug 09, 2023	SELL	$1.44 - $2.19 $633 - $963	-440 Reduced 0.27%	159,897 $275,000
Q1 2023 May 09, 2023	SELL	$1.17 - $2.7 $55,801 - $128,773	-47,694 Reduced 22.93%	160,337 $290,000
Q4 2022 Feb 14, 2023	BUY	$2.38 - $3.55 $41,485 - $61,880	17,431 Added 9.15%	208,031 $553,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $4.87 $162,956 - $252,738	51,897 Added 37.42%	190,600 $631,000
Q2 2022 Aug 08, 2022	BUY	$3.03 - $5.32 $56,588 - $99,356	18,676 Added 15.56%	138,703 $505,000
Q1 2022 May 09, 2022	BUY	$4.66 - $7.66 $199,662 - $328,200	42,846 Added 55.51%	120,027 $611,000
Q4 2021 Jan 31, 2022	BUY	$6.82 - $17.8 $446,184 - $1.16 Million	65,423 Added 556.41%	77,181 $589,000
Q3 2021 Nov 04, 2021	BUY	$13.62 - $19.48 $160,143 - $229,045	11,758 New	11,758 $174,000

Others Institutions Holding ATAI

# of Institutions

Shares Held

12.4M

Call Options Held

77.8K

Put Options Held

50.3K

View Full List

About ATAI Life Sciences N.V.

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

More about ATAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Shares Investments LLC with notifications on news.

Account

Advisor Shares Investments LLC Atai Life Sciences N.V. Transaction History